{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:21:24Z","timestamp":1768317684349,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.clinthera.2011.06.012","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T21:34:01Z","timestamp":1311716041000},"page":"1084-1095.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Time Trade-Off Procedure for Measuring Health Utilities Loss With Human Papillomavirus\u2013Induced Diseases: A Multicenter, Retrospective, Observational Pilot Study in Italy"],"prefix":"10.1016","volume":"33","author":[{"given":"Francesco Saverio","family":"Mennini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Panatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Marcellusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cristoforoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"De Vincenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Di Capua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Ferrandina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Petrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nausica","family":"Trivellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Capone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.06.012_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clinthera.2011.06.012_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.1866","article-title":"HPV-mediated cervical carcinogenesis: concepts and clinical implications","volume":"208","author":"Snijders","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.clinthera.2011.06.012_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"key":"10.1016\/j.clinthera.2011.06.012_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.clinthera.2011.06.012_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/oxfordjournals.jncimonographs.a003472","article-title":"Chapter 16: Prophylactic human papillomavirus vaccines","volume":"31","author":"Lowy","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clinthera.2011.06.012_bib7","author":"Ferlay"},{"key":"10.1016\/j.clinthera.2011.06.012_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2471\/BLT.06.038414","article-title":"Human papillomavirus and HPV vaccines: a review","volume":"85","author":"Cutts","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.clinthera.2011.06.012_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clinthera.2011.06.012_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.290.6.781","article-title":"Potential health and economic impact of adding a human papillomavirus vaccine to screening programmes","volume":"290","author":"Kulasingam","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.06.012_bib11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3201\/eid1011.040222","article-title":"Evaluating human papillomavirus vaccination programmes","volume":"10","author":"Taira","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clinthera.2011.06.012_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/jnci\/djh104","article-title":"Projected clinical benefits and cost-effectiveness of a human papillomavirus 16\/18 vaccine","volume":"96","author":"Goldie","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clinthera.2011.06.012_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1371\/journal.pmed.0030138","article-title":"Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses","volume":"3","author":"Barnabas","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","article-title":"Model for assessing human papillomavirus vaccination strategies","volume":"13","author":"Elbasha","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clinthera.2011.06.012_bib15","author":"Favato"},{"key":"10.1016\/j.clinthera.2011.06.012_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3201\/eid1402.070499","article-title":"Cost-effectiveness of human papillomavirus vaccination in the United States","volume":"14","author":"Chesson","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clinthera.2011.06.012_bib17","doi-asserted-by":"crossref","first-page":"a769","DOI":"10.1136\/bmj.a769","article-title":"Economic evaluation of human papillomavirus vaccination in the United Kingdom","volume":"337","author":"Jit","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2011.06.012_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/0003-4819-151-8-200910200-00007","article-title":"Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States","volume":"151","author":"Kim","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ygyno.2008.09.031","article-title":"Health and economic impact associated with a quadrivalent HPV vaccine in Italy","volume":"112","author":"Mennini","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinthera.2011.06.012_bib21","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1016\/j.vaccine.2009.02.052","article-title":"Anti-HPV vaccination: A review of recent economic data for Italy","volume":"27","author":"Mennini","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2011.06.012_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1287\/opre.28.1.206","article-title":"Utility functions for life years and health status","volume":"28","author":"Pliskin","year":"1980","journal-title":"Operations Res"},{"key":"10.1016\/j.clinthera.2011.06.012_bib24","series-title":"The Economics of Rationality","first-page":"149","article-title":"Disparities between health state measures: is there a rational explanation?","author":"Loomes","year":"1993"},{"key":"10.1016\/j.clinthera.2011.06.012_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2165\/00019053-199201050-00005","article-title":"Preference based outcome measures for economic evaluation of drug interventions: quality adjusted life years (QALYs) versus healthy years equivalents (HYEs)","volume":"1","author":"Mehrez","year":"1992","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.clinthera.2011.06.012_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5030","article-title":"Equity and the economic evaluation of healthcare","volume":"5","author":"Sassi","year":"2001","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.clinthera.2011.06.012_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1258\/135581904322716111","article-title":"Roughly right or precisely wrong?","volume":"9","author":"Arnesen","year":"2004","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.clinthera.2011.06.012_bib28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0272989X8500500208","article-title":"Parameter estimates for a QALY utility model","volume":"5","author":"Miyamoto","year":"1985","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2011.06.012_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/heapol\/czl018","article-title":"Calculating QALYs, comparing QALY and DALY calculations","volume":"21","author":"Sassi","year":"2006","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.clinthera.2011.06.012_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2010.06.025","article-title":"Hospital costs incurred by the Italian National Health Service for invasive cervical cancer","volume":"119","author":"Ferrandina","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinthera.2011.06.012_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1185\/03007995.2010.546730","article-title":"Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study","volume":"27","author":"Costa","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2011.06.012_bib33","first-page":"118","article-title":"A Utility maximization model for evaluation of heath care programs","volume":"7","author":"Torrance","year":"1972","journal-title":"Health Serv Res"},{"key":"10.1016\/j.clinthera.2011.06.012_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0038-0121(76)90036-7","article-title":"Social preferences for health states: an empirical evaluation of three measurement techniques","volume":"10","author":"Torrance","year":"1976","journal-title":"Socioeconomic Plan Sci"},{"key":"10.1016\/j.clinthera.2011.06.012_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1287\/mnsc.30.4.440","article-title":"Risk attitude and time preference in health","volume":"30","author":"Gafni","year":"1984","journal-title":"Manage Sci"},{"key":"10.1016\/j.clinthera.2011.06.012_bib36","author":"Furlong"},{"key":"10.1016\/j.clinthera.2011.06.012_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib39","series-title":"Cost-Effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.clinthera.2011.06.012_bib40","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"1997"},{"key":"10.1016\/j.clinthera.2011.06.012_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/089686088400400107","article-title":"Quality of life in end-stage renal disease","volume":"4","author":"Churchill","year":"1984","journal-title":"Periton Dial Bull"},{"key":"10.1016\/j.clinthera.2011.06.012_bib43","first-page":"14","article-title":"Measurement of quality of life in end-stage renal disease: the time trade-off approach","volume":"10","author":"Churchill","year":"1987","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0895-4356(92)90099-9","article-title":"Variability among methods to assess patients\u2019 well-being and consequent effect on a cost-effectiveness analysis","volume":"45","author":"Hornberger","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2011.06.012_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF00449917","article-title":"Quality of life of patients with end stage renal disease: a structural equation model","volume":"5","author":"Molzahn","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clinthera.2011.06.012_bib46","unstructured":"Lenert LA, Hornberger JC. Computer-assisted quality of life assessment for clinical trials. Proceedings of the American Medical Informatics Association, Annual Fall Symposium. 1996:992\u2013996."},{"key":"10.1016\/j.clinthera.2011.06.012_bib47","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/ndt\/12.10.2111","article-title":"Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients","volume":"12","author":"Sesso","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2011.06.012_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-127-3-199708010-00003","article-title":"Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults","volume":"127","author":"Hamel","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2011.06.012_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00005650-198406000-00005","article-title":"Describing health states","volume":"22","author":"Llewellyn-Thomas","year":"1984","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2011.06.012_bib50","series-title":"Decision Making: Descriptive, Normative, and Prescriptive Interactions","first-page":"562","article-title":"On the framing of medical decisions","author":"McNeil","year":"1988"},{"key":"10.1016\/j.clinthera.2011.06.012_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0272989X0102100505","article-title":"Assessing values for health: numeracy matters","volume":"21","author":"Woloshin","year":"2001","journal-title":"Med Decis Making"},{"key":"10.1016\/j.clinthera.2011.06.012_bib52","first-page":"295","article-title":"Quality of life assessment software for computer-inexperienced older adults: multimedia utility elicitation for activities of daily living","author":"Goldstein","year":"2002","journal-title":"Proc AMIA Symp"},{"key":"10.1016\/j.clinthera.2011.06.012_bib53","first-page":"992","article-title":"Computer-assisted quality of life assessment for clinical trials","author":"Lenert","year":"1996","journal-title":"Proc AMIA Annu Fall Symp"},{"key":"10.1016\/j.clinthera.2011.06.012_bib54","series-title":"Foundations of Behavioral Research","author":"Kerlinger","year":"1986"},{"key":"10.1016\/j.clinthera.2011.06.012_bib55","series-title":"Decision Making in Health Care: Theory, Psychology, and Applications","first-page":"313","article-title":"Applying utility assessment at the \u201cbedside.\u201d","author":"Goldstein","year":"2000"},{"key":"10.1016\/j.clinthera.2011.06.012_fr1","author":"Furlong"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811004231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811004231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:30Z","timestamp":1758962910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811004231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0149291811004231"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.06.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time Trade-Off Procedure for Measuring Health Utilities Loss With Human Papillomavirus\u2013Induced Diseases: A Multicenter, Retrospective, Observational Pilot Study in Italy","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}